GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (SHSE:688505) » Definitions » Days Inventory

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (SHSE:688505) Days Inventory : 379.98 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Average Total Inventories for the three months ended in Mar. 2024 was ¥45.3 Mil. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥10.9 Mil. Hence, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory for the three months ended in Mar. 2024 was 379.98.

The historical rank and industry rank for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory or its related term are showing as below:

SHSE:688505' s Days Inventory Range Over the Past 10 Years
Min: 89.53   Med: 166.74   Max: 257.54
Current: 257.54

During the past 13 years, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's highest Days Inventory was 257.54. The lowest was 89.53. And the median was 166.74.

SHSE:688505's Days Inventory is ranked worse than
77.98% of 972 companies
in the Drug Manufacturers industry
Industry Median: 158.805 vs SHSE:688505: 257.54

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory increased from Mar. 2023 (213.20) to Mar. 2024 (379.98). It might indicate that Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Inventory Turnover for the three months ended in Mar. 2024 was 0.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Inventory-to-Revenue for the three months ended in Mar. 2024 was 0.31.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Inventory Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Inventory Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 159.02 191.13 161.49 165.33 217.51

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 213.20 186.58 308.94 247.00 379.98

Competitive Comparison of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory falls into.



Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (40.527 + 43.651) / 2 ) / 70.628*365
=42.089 / 70.628*365
=217.51

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

Days Inventory (Q: Mar. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (43.651 + 46.92) / 2 ) / 10.875*365 / 4
=45.2855 / 10.875*365 / 4
=379.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co  (SHSE:688505) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Days Inventory Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (SHSE:688505) Business Description

Traded in Other Exchanges
Address
No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (SHSE:688505) Headlines

No Headlines